Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$0.08 - $21.0 $368 - $96,600
-4,600 Reduced 3.16%
140,925 $9,000
Q2 2022

Aug 01, 2022

SELL
$0.16 - $0.47 $5,440 - $15,980
-34,000 Reduced 18.94%
145,525 $24,000
Q1 2022

May 09, 2022

SELL
$0.42 - $0.62 $7,245 - $10,695
-17,250 Reduced 8.77%
179,525 $84,000
Q3 2021

Nov 04, 2021

SELL
$1.21 - $1.8 $12,100 - $18,000
-10,000 Reduced 4.84%
196,775 $327,000
Q2 2021

Aug 10, 2021

SELL
$1.56 - $1.98 $12,168 - $15,444
-7,800 Reduced 3.64%
206,775 $345,000
Q4 2020

Jan 29, 2021

SELL
$0.75 - $2.76 $19,687 - $72,450
-26,250 Reduced 10.9%
214,575 $341,000
Q3 2020

Oct 28, 2020

SELL
$0.61 - $1.17 $11,590 - $22,230
-19,000 Reduced 7.31%
240,825 $211,000
Q1 2020

May 06, 2020

SELL
$0.36 - $0.74 $1,800 - $3,700
-5,000 Reduced 1.89%
259,825 $108,000
Q4 2019

Feb 03, 2020

SELL
$0.35 - $0.58 $14,699 - $24,360
-42,000 Reduced 13.69%
264,825 $154,000
Q3 2019

Nov 12, 2019

BUY
$0.38 - $0.52 $7,068 - $9,672
18,600 Added 6.45%
306,825 $154,000
Q2 2019

Aug 12, 2019

BUY
$0.39 - $0.7 $21,060 - $37,800
54,000 Added 23.05%
288,225 $112,000
Q1 2019

May 06, 2019

BUY
$0.43 - $0.68 $6,880 - $10,880
16,000 Added 7.33%
234,225 $132,000
Q4 2018

Feb 05, 2019

SELL
$0.39 - $0.7 $40,755 - $73,150
-104,500 Reduced 32.38%
218,225 $86,000
Q3 2018

Oct 31, 2018

BUY
$0.44 - $3.02 $440 - $3,020
1,000 Added 0.31%
322,725 $164,000
Q2 2018

Aug 08, 2018

BUY
$1.66 - $3.82 $257,839 - $593,341
155,325 Added 93.34%
321,725 $708,000
Q1 2018

May 03, 2018

BUY
$2.16 - $3.48 $125,280 - $201,840
58,000 Added 53.51%
166,400 $566,000
Q4 2017

Jan 31, 2018

BUY
$0.68 - $4.19 $24,752 - $152,516
36,400 Added 50.56%
108,400 $441,000
Q3 2017

Nov 07, 2017

BUY
$0.38 - $0.66 $27,360 - $47,520
72,000
72,000 $44,000

Others Institutions Holding AMPE

# of Institutions
1
Shares Held
96.6K
Call Options Held
0
Put Options Held
0

About Ampio Pharmaceuticals, Inc.


  • Ticker AMPE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 226,287,008
  • Description
  • Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an...
More about AMPE
Track This Portfolio

Track Cypress Capital Management LLC (Wy) Portfolio

Follow Cypress Capital Management LLC (Wy) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cypress Capital Management LLC (Wy), based on Form 13F filings with the SEC.

News

Stay updated on Cypress Capital Management LLC (Wy) with notifications on news.